Search results for

The new film The Queen looks at England's royal family following the death of Princess Diana. It's directed by Stephen Frears and features Helen Mirren as Queen Elizabeth II. The movie opened the New York Film Festival on Friday. NPR critic Bob Mondello has a review.

The movie version of the controversial book The Yacoubian Building premiered this week in Cairo. The all-star production, the most expensive film ever in Egypt, touches on topics that are often taboo, such as Islamic extremism and homosexuality. It's opening at a time when the Egyptian government is taking a hard line on most expressions of dissent.

Fifty years ago, poet Allen Ginsberg gave the first public reading of "Howl" at a gathering in San Francisco. It was a literary milestone: Many consider that night the birth of the Beat Generation. Ginsberg's friend and fellow poet, Gary Snyder also read that night and recalls the event.

When Detroit milliner Luke Song made Aretha Franklin's now-iconic 2009 inaugural hat — you know, the one with the big bow? — he had no idea he'd be making thousands more.

The heads of the Indianapolis Museum of Art and the New Orleans Museum of Art have made a Super Bowl wager: The IMA will loan William Trevor's The Fifth Plague of Egypt, to NOMA if the Colts lose the Super Bowl. If the Saints lose, NOMA will loan Claude Lorrain's Ideal View of Tivoli.

Traveling westward along California's Route 66, the Santa Monica Pier rises just as the highway ends and the Pacific coast begins, its marquee Ferris wheel hovering majestically over the ocean. In celebration of the pier's centennial, Renee Montagne walks the wooden planks and speaks to some of the locals.

The former lead New York prosecutor investigating Donald Trump is slamming the Manhattan district attorney for putting the case on ice. He says he has no doubt the former president is guilty.

The letter came from Mark Pomerantz, who along with his co-leader in the Trump probe, resigned in February over the future of the case.

On Wall Street, the first quarter of 2022 was characterized by extreme volatility, as the Federal Reserve started to hike interest rates to fight surging inflation and Russia invaded Ukraine.

With the FDA poised to OK another booster for people 50 and older, questions remain: Is the evidence strong enough to warrant a fourth shot, does the timing make sense, and will there be much demand?